Related Experiment Video

Updated: Aug 11, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Microcystin produces disparate effects on liver cells in a dose dependent manner

Lars Herfindal1, Frode Selheim

  • 1Department of Biomedicine, Section of Anatomy and Cell Biology, The University of Bergen, Jonas Lies vei 91, N-5009 Bergen, Norway.

Mini Reviews in Medicinal Chemistry
|March 7, 2006
PubMed

Insights

Microcystin, a protein phosphatase inhibitor, impacts mammalian cells differently based on concentration. High doses cause cell death, while low doses promote survival, proliferation, and potentially liver cancer.

Area of Science:

  • Toxicology
  • Cell Biology
  • Biochemistry

Background:

  • Microcystins are potent toxins produced by cyanobacteria.
  • These toxins are known inhibitors of protein phosphatases 1 and 2A.
  • Their effects on mammalian cells are concentration-dependent and complex.

Purpose of the Study:

  • To review recent studies on microcystin's effects on mammalian cells.
  • To elucidate the dose-dependent mechanisms of microcystin toxicity and signaling.
  • To understand the link between microcystin exposure and liver cancer development.

Main Methods:

  • Review of existing scientific literature on microcystin.
  • Analysis of studies investigating cellular responses to varying microcystin concentrations.
  • Examination of signaling pathways involved in cell death, survival, and proliferation.

Main Results:

  • High microcystin concentrations induce reactive oxygen species (ROS)-mediated liver cell death, independent of typical apoptotic proteins.
  • Intermediate microcystin doses trigger classical apoptotic pathways.
  • Low microcystin concentrations enhance liver cell survival and proliferation, and are implicated in primary liver cancer.

Conclusions:

  • Microcystin exhibits a complex, dose-dependent toxicity profile in mammalian cells.
  • The concentration of microcystin dictates whether cells undergo death, apoptosis, or enhanced survival and proliferation.
  • Chronic exposure to low-level microcystin may represent a significant risk factor for primary liver cancer.

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...